154 related articles for article (PubMed ID: 38628504)
1. Temporal bone squamous cell carcinoma: Aggressive behavior coursing with cerebellar invasion and hydrocephalus.
de Castro MERV; Ferreira-Pinto PHC; de Oliveira Ferreira DBC; Brito ACG; Parise M; Correa EM; Cruz TZ; de Freitas WKN; de Gouvea PLRC; da Silva WN; de Sousa BC; Videira HFM; Parra GF; Nigri F
Surg Neurol Int; 2024; 15():89. PubMed ID: 38628504
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma of the temporal bone: A current review.
Lovin BD; Gidley PW
Laryngoscope Investig Otolaryngol; 2019 Dec; 4(6):684-692. PubMed ID: 31890889
[TBL] [Abstract][Full Text] [Related]
3. Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review.
Alessandrini L; Astolfi L; Franz L; Gentilin E; Mazzoni A; Zanoletti E; Marioni G
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562926
[TBL] [Abstract][Full Text] [Related]
4. Tumor budding to investigate local invasion, metastasis and prognosis in temporal bone squamous cell carcinoma.
Alessandrini L; Zanoletti E; Cazzador D; Sbaraglia M; Franz L; Tealdo G; Frigo AC; Blandamura S; Nicolai P; Mazzoni A; Marioni G
Pathol Res Pract; 2022 Jan; 229():153719. PubMed ID: 34953406
[TBL] [Abstract][Full Text] [Related]
5. Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.
Marioni G; Martini A; Favaretto N; Franchella S; Cappellesso R; Marino F; Blandamura S; Mazzoni A; Zanoletti E
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):2903-10. PubMed ID: 26518208
[TBL] [Abstract][Full Text] [Related]
6. Management of squamous cell carcinoma of the temporal bone: long-term results and factors influencing outcomes.
Piras G; Grinblat G; Albertini R; Sykopetrites V; Zhong SX; Lauda L; Sanna M
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3193-3202. PubMed ID: 32979119
[TBL] [Abstract][Full Text] [Related]
7. A critical look at persistent problems in the diagnosis, staging and treatment of temporal bone carcinoma.
Zanoletti E; Lovato A; Stritoni P; Martini A; Mazzoni A; Marioni G
Cancer Treat Rev; 2015 Dec; 41(10):821-6. PubMed ID: 26549119
[TBL] [Abstract][Full Text] [Related]
8. Recurrent squamous cell carcinoma of the temporal bone: critical analysis of cases with a poor prognosis.
Zanoletti E; Marioni G; Franchella S; Lovato A; Giacomelli L; Martini A; Mazzoni A
Am J Otolaryngol; 2015; 36(3):352-5. PubMed ID: 25595048
[TBL] [Abstract][Full Text] [Related]
9. Subtotal temporal bone resection en bloc with the parotid gland and temporomandibular joint: a 2-dimensional operative video.
Komune N; Kuga D; Hashimoto K; Fujiwara Y; Shimamoto R; Nakagawa T
Am J Otolaryngol; 2021; 42(4):103081. PubMed ID: 34052059
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.
Morita S; Nakamaru Y; Homma A; Yasukawa S; Hatakeyama H; Sakashita T; Kano S; Fukuda A; Fukuda S
Int J Clin Oncol; 2017 Feb; 22(1):181-189. PubMed ID: 27488595
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for treating temporal bone carcinoma based on long-term outcomes.
Bacciu A; Clemente IA; Piccirillo E; Ferrari S; Sanna M
Otol Neurotol; 2013 Jul; 34(5):898-907. PubMed ID: 23507994
[TBL] [Abstract][Full Text] [Related]
12. Temporal bone squamous cell carcinoma - Penang experience.
Ng SY; Pua KC; Zahirrudin Z
Med J Malaysia; 2015 Dec; 70(6):367-8. PubMed ID: 26988214
[TBL] [Abstract][Full Text] [Related]
13. Relaxin-2 expression in temporal bone carcinoma.
Marioni G; Zanoletti E; Lovato A; Franchella S; Giacomelli L; Gianatti A; Mazzoni A; Blandamura S; Martini A
Eur Arch Otorhinolaryngol; 2015 Nov; 272(11):3225-32. PubMed ID: 25388992
[TBL] [Abstract][Full Text] [Related]
14. Temporal bone carcinoma: Classical prognostic variables revisited and modern clinico-pathological evidence.
Zanoletti E; Marioni G; Franchella S; Munari S; Pareschi R; Mazzoni A; Martini A
Rep Pract Oncol Radiother; 2016; 21(4):386-90. PubMed ID: 27330424
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of temporal bone squamous cell carcinoma: A single-institution experience.
Zheng Y; Qiu K; Fu Y; Yang W; Cheng D; Rao Y; Mao M; Song Y; Xu W; Ren J; Zhao Y
Cancer Med; 2023 Mar; 12(5):5304-5311. PubMed ID: 36229984
[TBL] [Abstract][Full Text] [Related]
16. Progressive brainstem compression in an infant with neurocutaneous melanosis and Dandy-Walker complex following ventriculoperitoneal shunt placement for hydrocephalus. Case report.
McClelland S; Charnas LR; SantaCruz KS; Garner HP; Lam CH
J Neurosurg; 2007 Dec; 107(6 Suppl):500-3. PubMed ID: 18154021
[TBL] [Abstract][Full Text] [Related]
17. Temporal bone carcinoma: testing the prognostic value of a novel clinical and histological scoring system.
Franz L; Zanoletti E; Franchella S; Cazzador D; Favaretto N; Calvanese L; Mazzoni A; Nicolai P; Marioni G
Eur Arch Otorhinolaryngol; 2021 Nov; 278(11):4179-4186. PubMed ID: 33231758
[TBL] [Abstract][Full Text] [Related]
18. Temporal bone squamous cell carcinoma: A change in treatment.
Ngu CYV; Mohd Saad MS; Tang IP
Med J Malaysia; 2021 Sep; 76(5):725-730. PubMed ID: 34508382
[TBL] [Abstract][Full Text] [Related]
19. Endolymphatic sac tumor: case report and literature review.
Ge H; Wang H; Cai J; Zhang X; Mei W; Wu X; Kang D
Chin Neurosurg J; 2020; 6():16. PubMed ID: 32922945
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 Expression and Tumor-Infiltrating Lymphocytes in Temporal Bone Squamous Cell Carcinoma.
Hongo T; Kuga R; Miyazaki M; Komune N; Nakano T; Yamamoto H; Koike K; Sato K; Kogo R; Nabeshima K; Oda Y; Nakagawa T
Laryngoscope; 2021 Dec; 131(12):2674-2683. PubMed ID: 34143491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
